Skip to main navigation Skip to search Skip to main content

Post-donation SARS-CoV-2 identification among Thai blood donors

  • Duangnapa Intharasongkroh
  • , Kamin Wongkijpatana
  • , Aumnad Kongsup
  • , Aranya Nontapaoraya
  • , Kriangsak Chaiwong
  • , Sineenart Oota
  • , Jiratchaya Peunpa
  • , Sompong Vongpunsawad
  • , Suwimon Manopwisedjaroen
  • , Arunee Thitithanyanont
  • , Yong Poovorawan
  • , Pawinee Kupatawintu
  • , Pimol Chiewsilp
  • , Dootchai Chaiwanichsiri
  • Thai Red Cross Society
  • Faculty of Medicine, Chulalongkorn University
  • Mahidol University

Research output: Contribution to journal › Article › peer-review

Abstract

Introduction: Asymptomatic and mildly symptomatic individuals with COVID-19 may inadvertently donate blood because the COVID-19 screening test is not a prerequisite for blood donation. Although previous studies suggested that the risk of transfusion-transmitted COVID-19 is minimal, monitoring and evaluating the likelihood of SARS-CoV-2 transmission from transfusion remain important. Objective: To determine the potential risk of transfusion-transmitted SARS-CoV-2 infection. Materials and Methods: During the peak circulation of the SARS-CoV-2 Delta variant in Thailand from April to December 2021, the National Blood Centre collected blood from 448,025 donors; 158 donors (0.035%) self-reported a COVID-19 positive diagnosis either by the antigen test kit or by PCR within 7 days post-donation. Only 88 donor plasma samples available for testing were subjected to viral RNA detection by using the COBAS SARS-CoV-2 RNA assay. Further confirmatory testing of the positive samples with additional real-time reverse-transcription polymerase chain reaction (rRT-PCR) for the viral genome and sub-genome was performed. Results: One sample consistently tested positive for the ORF1a/b and the E gene on the COBAS, while four other samples were positive for either gene. All five samples (from donors 27-60 years of age) were negative upon re-testing with other assays for the viral genome and sub-genome. Two patients were uneventfully transfused with the blood components derived from this donor. Conclusion: Available data to date, including our study, suggested that SARS-CoV-2 transmission through transfusion was unlikely.

Original languageEnglish
Pages (from-to)251-259
Number of pages9
JournalJournal of Hematology and Transfusion Medicine
Volume33
Issue number4
Publication statusPublished - 1 Oct 2023
Externally publishedYes

Keywords

  • Blood donors
  • COVID-19
  • SARS-CoV-2 RNA

Cite this